Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab: the MARCOPOLO study

the MARCOPOLO investigators

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e298-e299
JournalJournal of the European Academy of Dermatology and Venereology
Volume31
Issue number6
DOIs
Publication statusPublished - 2017 Jun 1

All Science Journal Classification (ASJC) codes

  • Dermatology
  • Infectious Diseases

Cite this

@article{c7f66f945217497a8e40d3405b904e4f,
title = "Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab: the MARCOPOLO study",
author = "{the MARCOPOLO investigators} and Youn, {S. W.} and Kim, {B. R.} and S. Cho and Seo, {S. J.} and Lee, {E. S.} and Roh, {J. Y.} and Choi, {G. S.} and Mingeol Lee",
year = "2017",
month = "6",
day = "1",
doi = "10.1111/jdv.14083",
language = "English",
volume = "31",
pages = "e298--e299",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab

T2 - the MARCOPOLO study

AU - the MARCOPOLO investigators

AU - Youn, S. W.

AU - Kim, B. R.

AU - Cho, S.

AU - Seo, S. J.

AU - Lee, E. S.

AU - Roh, J. Y.

AU - Choi, G. S.

AU - Lee, Mingeol

PY - 2017/6/1

Y1 - 2017/6/1

UR - http://www.scopus.com/inward/record.url?scp=85007565958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007565958&partnerID=8YFLogxK

U2 - 10.1111/jdv.14083

DO - 10.1111/jdv.14083

M3 - Letter

C2 - 27976465

AN - SCOPUS:85007565958

VL - 31

SP - e298-e299

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 6

ER -